Editorial
Criteria, Categories, and Continua: Autism and Related Disorders in DSM-5

https://doi.org/10.1016/j.jaac.2011.03.015Get rights and content

References (11)

  • L. Wing et al.

    Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV?

    Res Dev Disabil

    (2011)
  • M.L. Mattila et al.

    Autism spectrum disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: an epidemiological study

    J Am Acad Child Adolesc Psychiatry

    (2011)
  • Proposed draft revisions to DSM disorders and criteria

  • A.N. Witwer et al.

    Validity of autism spectrum disorder subtypes

    J Autism Dev Disord

    (2008)
  • P. Howlin

    Outcome in high-functioning adults with autism with and without early language delays: Implications for the differentiation between autism and Asperger syndrome

    J Autism Dev Disord

    (2003)
There are more references available in the full text version of this article.

Cited by (65)

  • Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults

    2022, Vaccine
    Citation Excerpt :

    Vaccine hesitancy has been a paramount issue in the roll-out of COVID-19 vaccinations. Misinformation about the COVID-19 vaccine has been a rampant public health issue [10] and adults on the autism spectrum, given social and communication differences that are core aspects of a diagnosis of ASD [11], may be especially vulnerable to vaccine falsities being shared as has been demonstrated in other populations [10]. The decreased likelihood of COVID-19 vaccination among adults in areas that voted less often for President Biden indicates that community characteristics, including urbanicity, healthcare access, and political beliefs, likely impact autistic adults similarly to the overall population.

View all citing articles on Scopus

The author is grateful to all the members of the DSM-5 Neurodevelopmental Disorders Workgroup and their consultants for discussion of the issues raised in this editorial. Some of the points discussed in this editorial have also been raised in a piece by Dr. Happé for the Simons Foundation Web site.

Disclosure: Dr. Happé has received honorarium from Novartis and the University of Vienna.

View full text